Dasatinib, nilotinib, and standard dose imatinib for the first-line treatment of chronic myeloid leukaemia: systematic reviews and economic analyses

Martin Hoyle, Toby Pavey, Oriana Ciani, Louise Crathorne, Tracey Jones-Hughes , Chris Cooper, Leeza Osipenko, Meena Venkatachalam, Claudius Rudin, Obi Ukoumunne, Ruth Garside, Rob Anderson

Research output: Book/ReportCommissioned report

Original languageEnglish
PublisherUniversity of Exeter
Commissioning bodyNational Institute for Health and Care Excellence (NICE)
Number of pages242
Publication statusPublished - 2011
Externally publishedYes

Cite this